CIPO trademark

CAIRI

RegisteredCIPOWord markClass 5

"CAIRI" is a word mark owned by Mylan Pharmaceuticals, Inc., filed at the CIPO on August 18, 2020. It is registered and covers class 5 (Pharmaceuticals).

View Mylan Pharmaceuticals, Inc. portfolioGet this data via the API
Official CIPO record
CAIRI
Word mark as filed with the CIPO
Status
Registered
Since February 15, 2023
Filed
August 18, 2020
Registered
February 15, 2023
Expires
February 15, 2033
Application no.
2046293
Registration no.
TMA1165620
Office
CIPO
Canadian Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns CAIRI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Mylan Pharmaceuticals, Inc.

VTRS · United States

251 trademarks in the portfolioView company

Representative

Osler, Hoskin & Harcourt LLP

Osler, Hoskin & Harcourt LLP

Goods and services

What the mark covers

The products and services CAIRI is filed for, grouped by Nice class.

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Registered
  2. Registration Pending
  3. Advertised; Vol.69 Issue 3552
  4. Approval Notice Sent; APPROVED BY PROGRAM EX200M1
  5. Approved; APPROVED BY PROGRAM EX200M1
  6. Search Recorded
  7. Pre-Assessment Letter Sent; Acceptable Goods or Services
  8. Formalized
  9. Created
  10. Filed
FAQ

About CAIRI

Who owns the trademark "CAIRI"?

The CIPO trademark "CAIRI" (application 2046293) is owned by Mylan Pharmaceuticals, Inc.

What is the status of "CAIRI"?

Its status at the CIPO is: registered.

When was "CAIRI" registered?

It was registered on February 15, 2023 and is due to expire on February 15, 2033.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CAIRI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019deb30-0068-723a-bb62-816efdee5662
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019deb30-0068-723a-bb62-816efdee5662",
  "object": "trademark",
  "mark_text": "CAIRI",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "CA",
  "application_number": "2046293",
  "filing_date": "2020-08-18",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Mylan Pharmaceuticals, Inc.",
      "entity_id": "ent_019ebbc2-4d3e-716e-a817-eaf2bf4c073e"
    }
  ]
}